ARAV - Aravive Inc
IEX Last Trade
0.228
-0.020 -8.947%
Share volume: 6,895,081
Last Updated: Tue 08 Aug 2023 09:59:54 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.25
-0.02
-8.21%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2022-05-12 | 2022-08-11 | 2022-11-10 | 2023-03-15 | 2023-05-10 | 2023-08-21 | 2023-11-09 | |
Total revenue | 1.092 M | 1.615 M | 4.956 M | 1.474 M | 1.491 M | 1.274 M | 2.756 M | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 1.092 M | 1.615 M | 4.956 M | 1.474 M | 1.491 M | 1.274 M | 2.756 M | |
47.89% | 206.87% | -70.26% | 1.15% | -14.55% | 116.33% | |||
Operating expenses | 16.090 M | 21.042 M | 21.504 M | 21.338 M | 19.404 M | 13.860 M | 11.670 M | |
Selling general and admin | 3.088 M | 3.727 M | 2.836 M | 3.385 M | 3.489 M | 3.070 M | 2.940 M | |
Research and development | 13.002 M | 17.315 M | 18.668 M | 17.953 M | 15.915 M | 10.790 M | 8.730 M | |
Total expenses | 16.090 M | 21.042 M | 21.504 M | 21.338 M | 19.404 M | 13.860 M | 11.670 M | |
30.78% | 2.20% | -0.77% | -9.06% | -28.57% | -15.80% | |||
Operating income | -14.998 M | -19.427 M | -16.548 M | -19.864 M | -17.913 M | -12.586 M | -8.914 M | |
Ebit | -14.998 M | -19.427 M | -16.548 M | -19.864 M | -17.913 M | -12.586 M | -8.914 M | |
Pretax income | -13.057 M | -18.477 M | -15.663 M | -29.125 M | -49.956 M | 18.008 M | 21.226 M | |
41.51% | -15.23% | 85.95% | 71.52% | -136.05% | 17.87% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -13.057 M | -18.477 M | -15.663 M | -29.125 M | -49.956 M | 18.008 M | 21.226 M | |
-41.51% | 15.23% | -85.95% | -71.52% | 136.05% | 17.87% | |||
Net income | -13.057 M | -18.477 M | -15.663 M | -29.125 M | -49.956 M | 18.008 M | 21.226 M | |
-41.51% | 15.23% | -85.95% | -71.52% | 136.05% | 17.87% |